Influence of Seabed Morphology and Substrate Composition On Mass-Transport Flow Processes and Pathways: Insights From the Magdalena Fan, Offshore Colombia

Although the effects of interactions between turbidity currents and the seabed have been widely studied, the roles of substrate and bathymetry on the emplacement of mass-transport complexes (MTCs) remain poorly constrained. This study investigates the effect of bathymetric variability and substrate heterogeneity on the distribution, morphology, and internal characteristics of nine MTCs imaged within a 3D seismic volume in the southern Magdalena Fan, offshore Colombia. The MTCs overlie substrate units composed mainly of channel–levee-complex sets, with subsidiary deposits of MTCs. MTC dispersal was influenced by tectonic relief, associated with a thin-skinned, deep-water fold-and-thrust belt, and by depositional relief, associated with the underlying channel–levee-complex sets; it was the former that exerted the first-order control on the location of mass-transport pathways. Channel–levee-complex sets channelized, diverted, or blocked mass flows, with the style of response largely controlled by their orientation with respect to the direction of the incoming flow and by the height of the levees with respect to flow thickness. MTC erosion can be relatively deep above channel-fill deposits, whereas more subtle erosional morphologies are observed above adjacent levee units. In the largest MTC, the distribution of the seismic facies is well imaged, being influenced by the underlying bathymetry, with internal horizontal contraction occurring updip of bathymetric highs, erosion and bypass predominating above higher gradient slopes, and increased disaggregation characterizing the margins. Hence, bathymetric irregularities and substrate heterogeneity together influence the pathways, geometries, and internal characteristics of MTCs, which could in turn influence flow rheology, runout distances, the presence and continuity of underlying reservoirs, and the capacity of MTCs to act as either hydrocarbon seals or reservoirs

Influence of Seabed Morphology and Substrate Composition On Mass-Transport Flow Processes and Pathways: Insights From the Magdalena Fan, Offshore Colombia

Although the effects of interactions between turbidity currents and the seabed have been widely studied, the roles of substrate and bathymetry on the emplacement of mass-transport complexes (MTCs) remain poorly constrained. This study investigates the effect of bathymetric variability and substrate heterogeneity on the distribution, morphology, and internal characteristics of nine MTCs imaged within a 3D seismic volume in the southern Magdalena Fan, offshore Colombia. The MTCs overlie substrate units composed mainly of channel–levee-complex sets, with subsidiary deposits of MTCs. MTC dispersal was influenced by tectonic relief, associated with a thin-skinned, deep-water fold-and-thrust belt, and by depositional relief, associated with the underlying channel–levee-complex sets; it was the former that exerted the first-order control on the location of mass-transport pathways. Channel–levee-complex sets channelized, diverted, or blocked mass flows, with the style of response largely controlled by their orientation with respect to the direction of the incoming flow and by the height of the levees with respect to flow thickness. MTC erosion can be relatively deep above channel-fill deposits, whereas more subtle erosional morphologies are observed above adjacent levee units. In the largest MTC, the distribution of the seismic facies is well imaged, being influenced by the underlying bathymetry, with internal horizontal contraction occurring updip of bathymetric highs, erosion and bypass predominating above higher gradient slopes, and increased disaggregation characterizing the margins. Hence, bathymetric irregularities and substrate heterogeneity together influence the pathways, geometries, and internal characteristics of MTCs, which could in turn influence flow rheology, runout distances, the presence and continuity of underlying reservoirs, and the capacity of MTCs to act as either hydrocarbon seals or reservoirs

Field Experience Reimagined: Integrating Microteaches to Foster Preservice Teachers’ Self-Efficacy

The COVID-19 pandemic has had a significant impact on teacher preparation programs. With field experiences being among the most effective pathways to connect theory to practice and contributing significantly to preservice teachers’ self-efficacy development, teacher preparation programs have had to reimagine these experiences. In this article, the authors share how their teacher preparation program incorporated microteaches to continue fostering self-efficacy during pandemic times and the potential implications of these programmatic adaptations

NGSmethDB: a database for next-generation sequencing single-cytosine-resolution DNA methylation data

Next-generation sequencing (NGS) together with bisulphite conversion allows the generation of whole genome methylation maps at single-cytosine resolution. This allows studying the absence of methylation in a particular genome region over a range of tissues, the differential tissue methylation or the changes occurring along pathological conditions. However, no database exists fully addressing such requirements. We propose here NGSmethDB (http://bioinfo2.ugr.es/NGSmethDB/gbrowse/) for the storage and retrieval of methylation data derived from NGS. Two cytosine methylation contexts (CpG and CAG/CTG) are considered. Through a browser interface coupled to a MySQL backend and several data mining tools, the user can search for methylation states in a set of tissues, retrieve methylation values for a set of tissues in a given chromosomal region, or display the methylation of promoters among different tissues. NGSmethDB is currently populated with human, mouse and Arabidopsis data, but other methylomes will be incorporated through an automatic pipeline as soon as new data become available. Dump downloads for three coverage levels (1, 5 or 10 reads) are available. NGSmethDB will be useful for experimental researchers, as well as for bioinformaticians, who might use the data as input for further research

Increased Expression of Androgen Receptor Coregulator MAGE-11 in Prostate Cancer by DNA Hypomethylation and Cyclic AMP

Melanoma antigen gene protein-A11 (MAGE-11) of the MAGE family of cancer-germline antigens increases androgen receptor (AR) transcriptional activity through its interaction with the AR NH2-terminal FXXLF motif. The present study investigated the regulatory mechanisms that control MAGE-11 expression during androgen deprivation therapy and prostate cancer progression. Studies include the CWR22 xenograft model of human prostate cancer, clinical specimens of benign and malignant prostate, and prostate cancer cell lines. MAGE-11 mRNA levels increased 100 to 1500 fold during androgen deprivation therapy and prostate cancer progression, with highest levels in the castration-recurrent CWR22 xenograft and clinical specimens of castration-recurrent prostate cancer. Pyrosequencing of genomic DNA from prostate cancer specimens and cell lines indicated the increase in MAGE-11 resulted from DNA hypomethylation of a CpG island in the 5´ promoter of the MAGE-11 gene. Sodium bisulfite sequencing of genomic DNA from benign and malignant prostate tumors and prostate cancer cell lines revealed DNA hypomethylation at individual CpG sites at the transcription start site were most critical for MAGE-11 expression. Cyclic AMP also increased MAGE-11 expression and AR transcriptional activity in prostate cancer cell lines. However, cyclic AMP did not alter DNA methylation of the promoter and its effects were inhibited by extensive DNA methylation in the MAGE-11 promoter region. Increased expression of the AR coregulator MAGE-11 through promoter DNA hypomethylation and cyclic AMP provides a novel mechanism for increased AR signaling in castration-recurrent prostate cancer

Impact of generic alendronate cost on the cost-effectiveness of osteoporosis screening and treatment

Introduction: Since alendronate became available in generic form in the Unites States in 2008, its price has been decreasing. The objective of this study was to investigate the impact of alendronate cost on the cost-effectiveness of osteoporosis screening and treatment in postmenopausal women. Methods: Microsimulation cost-effectiveness model of osteoporosis screening and treatment for U.S. women age 65 and older. We assumed screening initiation at age 65 with central dual-energy x-ray absorptiometry (DXA), and alendronate treatment for individuals with osteoporosis; with a comparator of "no screening" and treatment only after fracture occurrence. We evaluated annual alendronate costs of $20 through$800; outcome measures included fractures; nursing home admission; medication adverse events; death; costs; quality-adjusted life-years (QALYs); and incremental cost-effectiveness ratios (ICERs) in 2010 U.S. dollars per QALY gained. A lifetime time horizon was used, and direct costs were included. Base-case and sensitivity analyses were performed. Results: Base-case analysis results showed that at annual alendronate costs of $200 or less, osteoporosis screening followed by treatment was cost-saving, resulting in lower total costs than no screening as well as more QALYs (10.6 additional quality-adjusted life-days). When assuming alendronate costs of$400 through $800, screening and treatment resulted in greater lifetime costs than no screening but was highly cost-effective, with ICERs ranging from$714 per QALY gained through $13,902 per QALY gained. Probabilistic sensitivity analyses revealed that the cost-effectiveness of osteoporosis screening followed by alendronate treatment was robust to joint input parameter estimate variation at a willingness-to-pay threshold of$50,000/QALY at all alendronate costs evaluated. Conclusions: Osteoporosis screening followed by alendronate treatment is effective and highly cost-effective for postmenopausal women across a range of alendronate costs, and may be cost-saving at annual alendronate costs of $200 or less. © 2012 Nayak et al

Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs

N8, a new recombinant factor VIII (rFVIII) compound developed for the treatment of haemophilia A, is produced in Chinese hamster ovary (CHO) cells and formulated without human- or animal-derived materials. The aim of the present study was to compare the pharmacokinetics (PK) and the procoagulant effect, measured by ex vivo whole blood clot formation, of N8 and a commercial rFVIII in a cross-over study in haemophilia A dogs. N8 and Advate® (100 IU kg−1) were administered intravenously to three haemophilia A dogs. Blood was sampled between 0 and 120 h postdose and FVIII:C analysed. PK parameters maximum plasma concentration, area under the curve, half-life (t½), clearance, mean residence time (MRT) and volume of distribution and incremental recovery were calculated. Whole blood clotting time (WBCT) and thromboelastography (TEG®) were used to determine the haemostatic potential. No adverse reactions were observed with N8 or Advate®. N8 and Advate® exhibited similar PK parameters, with t½ 7.7–11 h and MRT 11–14 h. Both rFVIII compounds corrected the prolonged WBCT (>48 min) to the range of normal dogs (8–12 min), i.e. N8 to 7.5–10.5 min and Advate® to 7.5–11.5 min. N8 and Advate® also normalized the whole blood clot formation according to TEG®. The native whole blood clotting assays (WBCT, TEG®) appeared to be more sensitive to low concentrations of FVIII than assays in citrated plasma samples. In conclusion, comparison of N8 and Advate® in haemophilia A dogs revealed similar safety, similar PK and similar effects in whole blood clot formation assays

Nanoethics, science communication, and a fourth model for public engagement

This paper develops a fourth model of public engagement with science, grounded in the principle of nurturing scientific agency through online participatory bioethics. It argues that social media is an effective device through which to enable such engagement, as it has the capacity to empower users and transforms audiences into co-producers of knowledge, rather than consumers of content, the value of which is recognised within the citizen science movement. Social media also fosters greater engagement with the political and legal implications of science, thus promoting the value of scientific citizenship through the acquisition of science capital. This argument is explored by considering the case of nanoscience and nanotechnology, as an exemplar for how emerging technologies may be handled by the scientific community and science policy makers, and as a technology that has defined a second era of science communication

DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11

MAGEA11 is a cancer germline (CG) antigen and androgen receptor co-activator. Its expression in cancers other than prostate, and its mechanism of activation, has not been reported. In silico analyses reveal that MAGEA11 is frequently expressed in human cancers, is increased during tumor progression, and correlates with poor prognosis and survival. In prostate and epithelial ovarian cancers (EOC), MAGEA11 expression was associated with promoter and global DNA hypomethylation, and with activation of other CG genes. Pharmacological or genetic inhibition of DNA methyltransferases (DNMTs) and/or histone deacetylases (HDACs) activated MAGEA11 in a cell line specific manner. MAGEA11 promoter activity was directly repressed by DNA methylation, and partially depended on Sp1, as pharmacological or genetic targeting of Sp1 reduced MAGEA11 promoter activity and endogenous gene expression. Importantly, DNA methylation regulated nucleosome occupancy specifically at the -1 positioned nucleosome of MAGEA11. Methylation of a single Ets site near the transcriptional start site (TSS) correlated with -1 nucleosome occupancy and, by itself, strongly repressed MAGEA11 promoter activity. Thus, DNA methylation regulates nucleosome occupancy at MAGEA11, and this appears to function cooperatively with sequence-specific transcription factors to regulate gene expression. MAGEA11 regulation is highly instructive for understanding mechanisms regulating CG antigen genes in human cancer

HDAC Inhibitors Act with 5-aza-2′-Deoxycytidine to Inhibit Cell Proliferation by Suppressing Removal of Incorporated Abases in Lung Cancer Cells

5-aza-2′-deoxycytidine (5-aza-CdR) is used extensively as a demethylating agent and acts in concert with histone deacetylase inhibitors (HDACI) to induce apoptosis or inhibition of cell proliferation in human cancer cells. Whether the action of 5-aza-CdR in this synergistic effect results from demethylation by this agent is not yet clear. In this study we found that inhibition of cell proliferation was not observed when cells with knockdown of DNA methyltransferase 1 (DNMT1), or double knock down of DNMT1-DNMT3A or DNMT1-DNMT3B were treated with HDACI, implying that the demethylating function of 5-aza-CdR may be not involved in this synergistic effect. Further study showed that there was a causal relationship between 5-aza-CdR induced DNA damage and the amount of [3H]-5-aza-CdR incorporated in DNA. However, incorporated [3H]-5-aza-CdR gradually decreased when cells were incubated in [3H]-5-aza-CdR free medium, indicating that 5-aza-CdR, which is an abnormal base, may be excluded by the cell repair system. It was of interest that HDACI significantly postponed the removal of the incorporated [3H]-5-aza-CdR from DNA. Moreover, HDAC inhibitor showed selective synergy with nucleoside analog-induced DNA damage to inhibit cell proliferation, but showed no such effect with other DNA damage stresses such as γ-ray and UV, etoposide or cisplatin. This study demonstrates that HDACI synergistically inhibits cell proliferation with nucleoside analogs by suppressing removal of incorporated harmful nucleotide analogs from DNA